Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
38,278,856
-
Share change
-
+213,919
-
Total reported value
-
$2,287,865,048
-
Put/Call ratio
-
31%
-
Price per share
-
$59.75
-
Number of holders
-
174
-
Value change
-
+$20,554,967
-
Number of buys
-
86
-
Number of sells
-
81
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q4 2017
As of 31 Dec 2017,
AERIE PHARMACEUTICALS INC - COM (AERI) was held by
174 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,278,856 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Partner Fund Management, L.P., Foresite Capital Management III, LLC, Foresite Capital Management II, LLC, JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, and STATE STREET CORP.
This page lists
174
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.